Accelerating Medicines Partnership
Organisation
Trials
Collaborator, Phase 2/3, Active, not recruiting, 197 people, 8 Mar 2022
Collaborator, Phase 2/3, Completed, 194 people, 10 Nov 2020
Collaborator, Phase 2/3, Active, not recruiting, 490 people, 3 Jan 2013
Funded papers
Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease
1 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov